Hyperfine (HYPR) Common Equity (2020 - 2026)
Hyperfine (HYPR) posted Common Equity of $34.4 million for Q1 2026, down 16.2% on a QoQ basis from $41.0 million in Q4 2025, and down 20.3% year-over-year from $43.1 million in Q1 2025.
Hyperfine (HYPR) Common Equity (2020 - 2026) Analysis & Trends
Hyperfine's Common Equity history runs 7 years deep, the most recent figure standing at $34.4 million for Q1 2026.
- Quarterly Common Equity fell 20.3% year-over-year to $34.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.4 million (down 20.3% YoY) and the FY2025 annual result came in at $41.0 million, down 16.38% from the prior year.
- Common Equity was $34.4 million for Q1 2026 at Hyperfine, down from $41.0 million in the prior quarter.
- Across five years, Common Equity topped out at $166.6 million in Q1 2022 and bottomed at $26.9 million in Q3 2025.
- A 5-year average of $82.4 million and a median of $75.6 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity soared 345.55% — and 2025, when it tumbled 53.92%.
- Hyperfine's Common Equity stood at $123.7 million in 2022, then sank by 31.78% to $84.4 million in 2023, then tumbled by 41.9% to $49.0 million in 2024, then retreated by 16.38% to $41.0 million in 2025, then slipped by 16.2% to $34.4 million in 2026.
- Business Quant data shows HYPR's Common Equity at $34.4 million in Q1 2026, $41.0 million in Q4 2025, and $26.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 34.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.36 Mn |
| Dec 31, 2025 | 41.01 Mn |
| Sep 30, 2025 | 26.87 Mn |
| Jun 30, 2025 | 35.13 Mn |
| Mar 31, 2025 | 43.11 Mn |
| Dec 31, 2024 | 49.04 Mn |
| Sep 30, 2024 | 58.32 Mn |
| Jun 30, 2024 | 66.76 Mn |
| Mar 31, 2024 | 75.64 Mn |
| Dec 31, 2023 | 84.40 Mn |
| Sep 30, 2023 | 93.77 Mn |
| Jun 30, 2023 | 103.29 Mn |
| Mar 31, 2023 | 112.74 Mn |
| Dec 31, 2022 | 123.72 Mn |
| Sep 30, 2022 | 134.98 Mn |
| Jun 30, 2022 | 150.51 Mn |
| Mar 31, 2022 | 166.56 Mn |
| Dec 31, 2021 | 186.23 Mn |
| Sep 30, 2021 | -101.06 Mn |
| Jun 30, 2021 | -87.31 Mn |